Appropriateness of red blood cell use in China in the last thirteen years: A systematic review

Objective: To determine both the rates of appropriate red blood cells (RBCs) use in China and where inappropriate use is particularly prevalent. Background: In China, obtaining the comprehensive picture in unnecessary RBCs transfusion is helpful for understanding the strained blood supplies and targ...

Full description

Bibliographic Details
Main Authors: Yujie Kong, Xiangming Wang, Yonghua Yin, Xue Tian, Ling Li, Jue Wang, Li Tian, Ning Song, Zhong Liu
Format: Article
Language:English
Published: Elsevier 2019-03-01
Series:Heliyon
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2405844018367811
id doaj-5ff4d0024fee4bdfb73fb15a3ad1f2cc
record_format Article
collection DOAJ
language English
format Article
sources DOAJ
author Yujie Kong
Xiangming Wang
Yonghua Yin
Xue Tian
Ling Li
Jue Wang
Li Tian
Ning Song
Zhong Liu
spellingShingle Yujie Kong
Xiangming Wang
Yonghua Yin
Xue Tian
Ling Li
Jue Wang
Li Tian
Ning Song
Zhong Liu
Appropriateness of red blood cell use in China in the last thirteen years: A systematic review
Heliyon
Evidence-based medicine
author_facet Yujie Kong
Xiangming Wang
Yonghua Yin
Xue Tian
Ling Li
Jue Wang
Li Tian
Ning Song
Zhong Liu
author_sort Yujie Kong
title Appropriateness of red blood cell use in China in the last thirteen years: A systematic review
title_short Appropriateness of red blood cell use in China in the last thirteen years: A systematic review
title_full Appropriateness of red blood cell use in China in the last thirteen years: A systematic review
title_fullStr Appropriateness of red blood cell use in China in the last thirteen years: A systematic review
title_full_unstemmed Appropriateness of red blood cell use in China in the last thirteen years: A systematic review
title_sort appropriateness of red blood cell use in china in the last thirteen years: a systematic review
publisher Elsevier
series Heliyon
issn 2405-8440
publishDate 2019-03-01
description Objective: To determine both the rates of appropriate red blood cells (RBCs) use in China and where inappropriate use is particularly prevalent. Background: In China, obtaining the comprehensive picture in unnecessary RBCs transfusion is helpful for understanding the strained blood supplies and targeting training of clinicians. Study design: and methods: Eligible studies were mainly retrieved from four Chinese medical databases and four databases from abroad. In all studies, the appropriateness of RBCs transfusion in transfusion cases, blood request forms, or RBC units within the last thirteen years was determined by using national guidelines. Relationships between RBCs-transfusion appropriateness and type of RBCs-transfusion record, geographical region, level of hospital (LOH-2 and LOH-3), department type (operative vs. non-operative), and study quality (high vs. low) were analyzed by Chi-squared tests. Results: On average, 72.30% (standard deviation, SD = 18.87%) of all cases/forms/units throughout China were appropriate. The appropriateness of RBCs-transfusion differed significantly depending on RBCs-transfusion record type, they were 69.10%, 68.85%, and 75.64% for blood request forms, transfusion cases, and RBCs units, respectively (p < 0.001). The southwest and northeast were the most (80.62%) and the least (66.57%) appropriate transfusion areas, respectively. The coefficients of variances (CV) for the geographical regions differed significantly (0.029–0.39). LOH-3 were more appropriate than LOH-2 (p < 0.001). Non-operative departments were more appropriate than operative departments (p < 0.001). High-quality studies reported higher appropriate rate than low-quality studies (74.48% vs. 69.72%, p < 0.001). Conclusion: In China, unnecessary RBCs transfusion was common and may exacerbate the current pressure on blood supplies. Clinicians in certain geographical regions, LOH-2, and operative departments should be targeted with training in transfusion medicine.
topic Evidence-based medicine
url http://www.sciencedirect.com/science/article/pii/S2405844018367811
work_keys_str_mv AT yujiekong appropriatenessofredbloodcelluseinchinainthelastthirteenyearsasystematicreview
AT xiangmingwang appropriatenessofredbloodcelluseinchinainthelastthirteenyearsasystematicreview
AT yonghuayin appropriatenessofredbloodcelluseinchinainthelastthirteenyearsasystematicreview
AT xuetian appropriatenessofredbloodcelluseinchinainthelastthirteenyearsasystematicreview
AT lingli appropriatenessofredbloodcelluseinchinainthelastthirteenyearsasystematicreview
AT juewang appropriatenessofredbloodcelluseinchinainthelastthirteenyearsasystematicreview
AT litian appropriatenessofredbloodcelluseinchinainthelastthirteenyearsasystematicreview
AT ningsong appropriatenessofredbloodcelluseinchinainthelastthirteenyearsasystematicreview
AT zhongliu appropriatenessofredbloodcelluseinchinainthelastthirteenyearsasystematicreview
_version_ 1724783002823688192
spelling doaj-5ff4d0024fee4bdfb73fb15a3ad1f2cc2020-11-25T02:40:06ZengElsevierHeliyon2405-84402019-03-0153e01408Appropriateness of red blood cell use in China in the last thirteen years: A systematic reviewYujie Kong0Xiangming Wang1Yonghua Yin2Xue Tian3Ling Li4Jue Wang5Li Tian6Ning Song7Zhong Liu8Clinical Transfusion Research Center, Institute of Blood Transfusion, Chinese Academy of Medical Sciences and Peking Union Medical College, Chengdu, China; Key Laboratory of Transfusion Adverse Reactions, CAMS, Chengdu, Sichuan, ChinaBeijing University of Chinese Medicine, Beijing, ChinaClinical Transfusion Research Center, Institute of Blood Transfusion, Chinese Academy of Medical Sciences and Peking Union Medical College, Chengdu, China; Key Laboratory of Transfusion Adverse Reactions, CAMS, Chengdu, Sichuan, ChinaClinical Transfusion Research Center, Institute of Blood Transfusion, Chinese Academy of Medical Sciences and Peking Union Medical College, Chengdu, China; Key Laboratory of Transfusion Adverse Reactions, CAMS, Chengdu, Sichuan, ChinaClinical Transfusion Research Center, Institute of Blood Transfusion, Chinese Academy of Medical Sciences and Peking Union Medical College, Chengdu, China; Key Laboratory of Transfusion Adverse Reactions, CAMS, Chengdu, Sichuan, ChinaClinical Transfusion Research Center, Institute of Blood Transfusion, Chinese Academy of Medical Sciences and Peking Union Medical College, Chengdu, China; Key Laboratory of Transfusion Adverse Reactions, CAMS, Chengdu, Sichuan, ChinaClinical Transfusion Research Center, Institute of Blood Transfusion, Chinese Academy of Medical Sciences and Peking Union Medical College, Chengdu, China; Key Laboratory of Transfusion Adverse Reactions, CAMS, Chengdu, Sichuan, ChinaClinical Transfusion Research Center, Institute of Blood Transfusion, Chinese Academy of Medical Sciences and Peking Union Medical College, Chengdu, China; Key Laboratory of Transfusion Adverse Reactions, CAMS, Chengdu, Sichuan, ChinaClinical Transfusion Research Center, Institute of Blood Transfusion, Chinese Academy of Medical Sciences and Peking Union Medical College, Chengdu, China; Key Laboratory of Transfusion Adverse Reactions, CAMS, Chengdu, Sichuan, China; Corresponding author.Objective: To determine both the rates of appropriate red blood cells (RBCs) use in China and where inappropriate use is particularly prevalent. Background: In China, obtaining the comprehensive picture in unnecessary RBCs transfusion is helpful for understanding the strained blood supplies and targeting training of clinicians. Study design: and methods: Eligible studies were mainly retrieved from four Chinese medical databases and four databases from abroad. In all studies, the appropriateness of RBCs transfusion in transfusion cases, blood request forms, or RBC units within the last thirteen years was determined by using national guidelines. Relationships between RBCs-transfusion appropriateness and type of RBCs-transfusion record, geographical region, level of hospital (LOH-2 and LOH-3), department type (operative vs. non-operative), and study quality (high vs. low) were analyzed by Chi-squared tests. Results: On average, 72.30% (standard deviation, SD = 18.87%) of all cases/forms/units throughout China were appropriate. The appropriateness of RBCs-transfusion differed significantly depending on RBCs-transfusion record type, they were 69.10%, 68.85%, and 75.64% for blood request forms, transfusion cases, and RBCs units, respectively (p < 0.001). The southwest and northeast were the most (80.62%) and the least (66.57%) appropriate transfusion areas, respectively. The coefficients of variances (CV) for the geographical regions differed significantly (0.029–0.39). LOH-3 were more appropriate than LOH-2 (p < 0.001). Non-operative departments were more appropriate than operative departments (p < 0.001). High-quality studies reported higher appropriate rate than low-quality studies (74.48% vs. 69.72%, p < 0.001). Conclusion: In China, unnecessary RBCs transfusion was common and may exacerbate the current pressure on blood supplies. Clinicians in certain geographical regions, LOH-2, and operative departments should be targeted with training in transfusion medicine.http://www.sciencedirect.com/science/article/pii/S2405844018367811Evidence-based medicine